All-In with Chamath, Jason, Sacks & Friedberg
All-In with Chamath, Jason, Sacks & Friedberg

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

1h 21min

This episode covers OpenAI's missed user and revenue targets, highlighting a strategic pivot towards enterprise AI and the critical constraint of power for compute. It also delves into Elon Musk's lawsuit against OpenAI, the massive CapEx investments by hyperscalers driven by AI demand, and the promising clinical trial results of Lily's new peptide, Retatrutide.

Summarized by Podsumo

Key Takeaways

💬 Notable Quotes

Get every episode summarized
Delivered to Telegram. Ask questions about any episode.
Start on Telegram